Global Alzheimer's Disease Market Research Report 2023

Report ID: 1900839 | Published Date: Sep 2024 | No. of Page: 87 | Base Year: 2023 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Alzheimer's Disease Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Donepezil
        1.2.3 Memantine
        1.2.4 Rivastigmine
    1.3 Market by Application
        1.3.1 Global Alzheimer's Disease Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Early to Moderate Stages
        1.3.3 Moderate to Severe Stages
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Alzheimer's Disease Market Perspective (2017-2028)
    2.2 Alzheimer's Disease Growth Trends by Region
        2.2.1 Alzheimer's Disease Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Alzheimer's Disease Historic Market Size by Region (2017-2022)
        2.2.3 Alzheimer's Disease Forecasted Market Size by Region (2023-2028)
    2.3 Alzheimer's Disease Market Dynamics
        2.3.1 Alzheimer's Disease Industry Trends
        2.3.2 Alzheimer's Disease Market Drivers
        2.3.3 Alzheimer's Disease Market Challenges
        2.3.4 Alzheimer's Disease Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Alzheimer's Disease Players by Revenue
        3.1.1 Global Top Alzheimer's Disease Players by Revenue (2017-2022)
        3.1.2 Global Alzheimer's Disease Revenue Market Share by Players (2017-2022)
    3.2 Global Alzheimer's Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Alzheimer's Disease Revenue
    3.4 Global Alzheimer's Disease Market Concentration Ratio
        3.4.1 Global Alzheimer's Disease Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Revenue in 2021
    3.5 Alzheimer's Disease Key Players Head office and Area Served
    3.6 Key Players Alzheimer's Disease Product Solution and Service
    3.7 Date of Enter into Alzheimer's Disease Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Alzheimer's Disease Breakdown Data by Type
    4.1 Global Alzheimer's Disease Historic Market Size by Type (2017-2022)
    4.2 Global Alzheimer's Disease Forecasted Market Size by Type (2023-2028)
5 Alzheimer's Disease Breakdown Data by Application
    5.1 Global Alzheimer's Disease Historic Market Size by Application (2017-2022)
    5.2 Global Alzheimer's Disease Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Alzheimer's Disease Market Size (2017-2028)
    6.2 North America Alzheimer's Disease Market Size by Country (2017-2022)
    6.3 North America Alzheimer's Disease Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Alzheimer's Disease Market Size (2017-2028)
    7.2 Europe Alzheimer's Disease Market Size by Country (2017-2022)
    7.3 Europe Alzheimer's Disease Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Alzheimer's Disease Market Size (2017-2028)
    8.2 Asia-Pacific Alzheimer's Disease Market Size by Country (2017-2022)
    8.3 Asia-Pacific Alzheimer's Disease Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Alzheimer's Disease Market Size (2017-2028)
    9.2 Latin America Alzheimer's Disease Market Size by Country (2017-2022)
    9.3 Latin America Alzheimer's Disease Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Alzheimer's Disease Market Size (2017-2028)
    10.2 Middle East & Africa Alzheimer's Disease Market Size by Country (2017-2022)
    10.3 Middle East & Africa Alzheimer's Disease Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Allergan
        11.1.1 Allergan Company Detail
        11.1.2 Allergan Business Overview
        11.1.3 Allergan Alzheimer's Disease Introduction
        11.1.4 Allergan Revenue in Alzheimer's Disease Business (2017-2022)
        11.1.5 Allergan Recent Development
    11.2 Eisai
        11.2.1 Eisai Company Detail
        11.2.2 Eisai Business Overview
        11.2.3 Eisai Alzheimer's Disease Introduction
        11.2.4 Eisai Revenue in Alzheimer's Disease Business (2017-2022)
        11.2.5 Eisai Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Detail
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Alzheimer's Disease Introduction
        11.3.4 Novartis Revenue in Alzheimer's Disease Business (2017-2022)
        11.3.5 Novartis Recent Development
    11.4 Daiichi Sankyo
        11.4.1 Daiichi Sankyo Company Detail
        11.4.2 Daiichi Sankyo Business Overview
        11.4.3 Daiichi Sankyo Alzheimer's Disease Introduction
        11.4.4 Daiichi Sankyo Revenue in Alzheimer's Disease Business (2017-2022)
        11.4.5 Daiichi Sankyo Recent Development
    11.5 Merz Pharma
        11.5.1 Merz Pharma Company Detail
        11.5.2 Merz Pharma Business Overview
        11.5.3 Merz Pharma Alzheimer's Disease Introduction
        11.5.4 Merz Pharma Revenue in Alzheimer's Disease Business (2017-2022)
        11.5.5 Merz Pharma Recent Development
    11.6 Pfizer
        11.6.1 Pfizer Company Detail
        11.6.2 Pfizer Business Overview
        11.6.3 Pfizer Alzheimer's Disease Introduction
        11.6.4 Pfizer Revenue in Alzheimer's Disease Business (2017-2022)
        11.6.5 Pfizer Recent Development
    11.7 Johnson & Johnson
        11.7.1 Johnson & Johnson Company Detail
        11.7.2 Johnson & Johnson Business Overview
        11.7.3 Johnson & Johnson Alzheimer's Disease Introduction
        11.7.4 Johnson & Johnson Revenue in Alzheimer's Disease Business (2017-2022)
        11.7.5 Johnson & Johnson Recent Development
    11.8 Lundbeck
        11.8.1 Lundbeck Company Detail
        11.8.2 Lundbeck Business Overview
        11.8.3 Lundbeck Alzheimer's Disease Introduction
        11.8.4 Lundbeck Revenue in Alzheimer's Disease Business (2017-2022)
        11.8.5 Lundbeck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Alzheimer's Disease Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Donepezil
    Table 3. Key Players of Memantine
    Table 4. Key Players of Rivastigmine
    Table 5. Global Alzheimer's Disease Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Alzheimer's Disease Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Alzheimer's Disease Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Alzheimer's Disease Market Share by Region (2017-2022)
    Table 9. Global Alzheimer's Disease Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Alzheimer's Disease Market Share by Region (2023-2028)
    Table 11. Alzheimer's Disease Market Trends
    Table 12. Alzheimer's Disease Market Drivers
    Table 13. Alzheimer's Disease Market Challenges
    Table 14. Alzheimer's Disease Market Restraints
    Table 15. Global Alzheimer's Disease Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Alzheimer's Disease Market Share by Players (2017-2022)
    Table 17. Global Top Alzheimer's Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease as of 2021)
    Table 18. Ranking of Global Top Alzheimer's Disease Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Alzheimer's Disease Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Alzheimer's Disease Product Solution and Service
    Table 22. Date of Enter into Alzheimer's Disease Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Alzheimer's Disease Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Alzheimer's Disease Revenue Market Share by Type (2017-2022)
    Table 26. Global Alzheimer's Disease Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Alzheimer's Disease Revenue Market Share by Type (2023-2028)
    Table 28. Global Alzheimer's Disease Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Alzheimer's Disease Revenue Market Share by Application (2017-2022)
    Table 30. Global Alzheimer's Disease Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Alzheimer's Disease Revenue Market Share by Application (2023-2028)
    Table 32. North America Alzheimer's Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Alzheimer's Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Alzheimer's Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Alzheimer's Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Alzheimer's Disease Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Alzheimer's Disease Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Alzheimer's Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Alzheimer's Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Alzheimer's Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Alzheimer's Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Allergan Company Detail
    Table 43. Allergan Business Overview
    Table 44. Allergan Alzheimer's Disease Product
    Table 45. Allergan Revenue in Alzheimer's Disease Business (2017-2022) & (US$ Million)
    Table 46. Allergan Recent Development
    Table 47. Eisai Company Detail
    Table 48. Eisai Business Overview
    Table 49. Eisai Alzheimer's Disease Product
    Table 50. Eisai Revenue in Alzheimer's Disease Business (2017-2022) & (US$ Million)
    Table 51. Eisai Recent Development
    Table 52. Novartis Company Detail
    Table 53. Novartis Business Overview
    Table 54. Novartis Alzheimer's Disease Product
    Table 55. Novartis Revenue in Alzheimer's Disease Business (2017-2022) & (US$ Million)
    Table 56. Novartis Recent Development
    Table 57. Daiichi Sankyo Company Detail
    Table 58. Daiichi Sankyo Business Overview
    Table 59. Daiichi Sankyo Alzheimer's Disease Product
    Table 60. Daiichi Sankyo Revenue in Alzheimer's Disease Business (2017-2022) & (US$ Million)
    Table 61. Daiichi Sankyo Recent Development
    Table 62. Merz Pharma Company Detail
    Table 63. Merz Pharma Business Overview
    Table 64. Merz Pharma Alzheimer's Disease Product
    Table 65. Merz Pharma Revenue in Alzheimer's Disease Business (2017-2022) & (US$ Million)
    Table 66. Merz Pharma Recent Development
    Table 67. Pfizer Company Detail
    Table 68. Pfizer Business Overview
    Table 69. Pfizer Alzheimer's Disease Product
    Table 70. Pfizer Revenue in Alzheimer's Disease Business (2017-2022) & (US$ Million)
    Table 71. Pfizer Recent Development
    Table 72. Johnson & Johnson Company Detail
    Table 73. Johnson & Johnson Business Overview
    Table 74. Johnson & Johnson Alzheimer's Disease Product
    Table 75. Johnson & Johnson Revenue in Alzheimer's Disease Business (2017-2022) & (US$ Million)
    Table 76. Johnson & Johnson Recent Development
    Table 77. Lundbeck Company Detail
    Table 78. Lundbeck Business Overview
    Table 79. Lundbeck Alzheimer's Disease Product
    Table 80. Lundbeck Revenue in Alzheimer's Disease Business (2017-2022) & (US$ Million)
    Table 81. Lundbeck Recent Development
    Table 82. Research Programs/Design for This Report
    Table 83. Key Data Information from Secondary Sources
    Table 84. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Alzheimer's Disease Market Share by Type: 2021 VS 2028
    Figure 2. Donepezil Features
    Figure 3. Memantine Features
    Figure 4. Rivastigmine Features
    Figure 5. Global Alzheimer's Disease Market Share by Application in 2021 & 2028
    Figure 6. Early to Moderate Stages Case Studies
    Figure 7. Moderate to Severe Stages Case Studies
    Figure 8. Alzheimer's Disease Report Years Considered
    Figure 9. Global Alzheimer's Disease Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Alzheimer's Disease Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Alzheimer's Disease Market Share by Region: 2021 VS 2028
    Figure 12. Global Alzheimer's Disease Market Share by Players in 2021
    Figure 13. Global Top Alzheimer's Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Alzheimer's Disease Revenue in 2021
    Figure 15. North America Alzheimer's Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Alzheimer's Disease Market Share by Country (2017-2028)
    Figure 17. United States Alzheimer's Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Alzheimer's Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Alzheimer's Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Alzheimer's Disease Market Share by Country (2017-2028)
    Figure 21. Germany Alzheimer's Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Alzheimer's Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Alzheimer's Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Alzheimer's Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Alzheimer's Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Alzheimer's Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Alzheimer's Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Alzheimer's Disease Market Share by Region (2017-2028)
    Figure 29. China Alzheimer's Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Alzheimer's Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Alzheimer's Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Alzheimer's Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Alzheimer's Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Alzheimer's Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Alzheimer's Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Alzheimer's Disease Market Share by Country (2017-2028)
    Figure 37. Mexico Alzheimer's Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Alzheimer's Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Alzheimer's Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Alzheimer's Disease Market Share by Country (2017-2028)
    Figure 41. Turkey Alzheimer's Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Alzheimer's Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Allergan Revenue Growth Rate in Alzheimer's Disease Business (2017-2022)
    Figure 44. Eisai Revenue Growth Rate in Alzheimer's Disease Business (2017-2022)
    Figure 45. Novartis Revenue Growth Rate in Alzheimer's Disease Business (2017-2022)
    Figure 46. Daiichi Sankyo Revenue Growth Rate in Alzheimer's Disease Business (2017-2022)
    Figure 47. Merz Pharma Revenue Growth Rate in Alzheimer's Disease Business (2017-2022)
    Figure 48. Pfizer Revenue Growth Rate in Alzheimer's Disease Business (2017-2022)
    Figure 49. Johnson & Johnson Revenue Growth Rate in Alzheimer's Disease Business (2017-2022)
    Figure 50. Lundbeck Revenue Growth Rate in Alzheimer's Disease Business (2017-2022)
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
Frequently Asked Questions
Alzheimer's Disease report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Alzheimer's Disease report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Alzheimer's Disease report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports